Default company panoramic image

Onciomed, Inc

Innovations in Obesity and Metabolic Technologies

  • Stage $1M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Irvine, CA, USA
  • Currency USD
  • Founded January 2009
  • Employees 7
  • Website

Company Summary

Onciomed, Inc. has developed a novel, patented, minimally-invasive, reversible, technology for the treatment of the ongoing, worldwide epidemic of obesity and diabetes. The US spends over $147 B in obesity and related problems. CDC describes obesity as #1 preventable cause of death in United States. It use to be smoking. Onciomed, Inc is fulfilling the unmet clinical need.


  • Default avatar
    Tom Silvestrini
    Director of R&D

    Thomas Silvestrini has worked in the medical device field for 24 years developing Class III implants in 10 surgical specialties. Most recently he was VP of R&D at an obesity technology company Vallentx. He began as a researcher for Pfizer pharmaceuticals leaving Pfizer as a research manager in 1990 to take his first executive position in a start up company. At KeraVision, he directed the development of the Intacts, the first and only corneal imp

  • Default avatar
    Dr. Raj Nihalani

    a physician by training, has 15 years of experience in the medical device industry. Dr. Nihalani began his career as a regulatory, technology assessment and clinical trial consultant for medical device companies like Guidant and B Braun, and held senior positions at Medtronic. He has also worked successfully with start-up organizations including Endologix (ELGX) acquired by Radiance Med Systems, AcuFocus (Acquired by B&L), Alvivo Vascular, and a

  • Default avatar
    Dr. Paul Stein, Ph.D
    Director of Research & Regulatory Affairs

    Paul received his doctorate in physiology from Albany Medical College, NY and following post-doctoral research moved on to industrial staff scientist and study director positions at Medtronic, Inc. His 15 years there were instrumental to bring many implantable and interventional cardiac rhythm management (CRM), heart failure, and sleep apnea devices into clinical studies and market release. He was presented with the prestigious Star of Excellen

  • Default avatar
    Dr. Dov Gal
    VP of Clincial Affairs

    Dov got his doctorate in veterinary medicine, he was recruited out of academia to head up R&D for a biotechnology start up that sprang out of discoveries made at MIT and Harvard University. In his 18 years in the med tech industry he held executive positions at Medtronic Vascular , Bronchus Technologies and, most recently, at Edwards Lifesciences as Sr. Director of Clinical Affairs
    He has deep interest in working on technologies that meet the u

  • Default avatar
    Glenn Morimoto
    VP of Marketing & Business Development

    Glenn has worked and consulted for several startup companies in the medical device space. From 1991- 2007 he was a Senior Executive with the largest Sugar Cooperative in the United States, heading their global sales, marketing & strategic planning force to major International accounts, primarily to the Far East and European countries. In addition, he managed all supply chain activities and customer service. He was the Operation Manager for a Japa

  • Default avatar
    Stephanie Sorrenson
    Director of Practice Development & Marketing

    Stephanie’s experience includes communications management for medical device and biotechnology companies. She has over 20 years experience in companies like Johnson & Johnson and Beckman Coulter.

    Her expertise in patient recruitment was sharpened at startups where her communications skill was matched with the development of essential tools for private practices to accelerate patient recruitment, procedural volume, enhance patient experience

  • Default avatar
    Lila Cheng
    Director of Finance

    Lila Has been with Onciomed since 2009. Previously worked in the corporate industry for15 years in LA and Orange county areas. She began her career in public accounting firms as the auditor and cost & finance consultant with multi-industries and clients base. Later, she joined a public traded electronic consumer product company worked as the Director of Finance & Business Operations  managing logistic and finance with SAP-ERP system, transfer pr


  • Default avatar
    Stradling Yocca Carlson & Rauth, LLP (Corporate), Snell & Wilmer , LLP ( I.P Attorneys)
    Default avatar
    Lila Cheng

Previous Investors

  • Default avatar
    US and OUS Investors